Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
| Image |  |
|---|---|
| Description | scientific article published on 15 April 2016 |
| Author/s |
author: Wattana Sukeepaisarnjaroen Masatoshi Kudo Ann-Lii Cheng Stephen L Chan |
| Publication date | April 15, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |